Founder Directory
Built by Keitoto
Founders3
Known for these resultsRole67%Role is parsed from founder titles in yc.db. Known for 67% of these rows — the rest have no title at all, mostly 2019–2023. Those rows stay in the result and are counted as Unknown, never as No.Bio100%Bio coverage: 100% of these founders have a bio on their YC profile. Every bio-derived facet (ex-company, school, credentials, discipline) is Unknown for the rest.Ex-company33%Ex-company is matched from bios with employment context (ex-, formerly, worked at). 33% of these rows have at least one match.School100%School is matched from bios, case-sensitive for acronyms. 100% of these rows have at least one match.
- Ian Shi@ianshi3Founder/CTO · Blank BioS25Healthcare · San Francisco
- Jonny Hsu@hsu_jonnyFounder/CEO · Blank BioS25Healthcare · San Francisco
- Philip Fradkin@phil_fradkinFounder · Blank BioS25Healthcare · San Francisco
FOUNDERROLEBATCHINDUSTRYLOCATIONTEAMX_url
Ian ShiBlank BioFounder/CTOSummer 2025HealthcareSan Francisco, United States6https://x.com/ianshi3Jonny HsuBlank BioFounder/CEOSummer 2025HealthcareSan Francisco, United States6https://x.com/hsu_jonnyPhilip FradkinBlank BioFounderSummer 2025HealthcareSan Francisco, United States6https://x.com/phil_fradkinShowing 1–3 of 3 founders
Jonny Hsu
Founder/CEO·Blank Bio
PRIMARY INFO
RoleFounder/CEO
Team size6
BatchSummer 2025
LocationSan Francisco, United States
Company statusActive
StageEarly
BIO
Working on foundation models for RNA therapeutics. I was an early employee at Valence Discovery, a biotech startup that spun out from Mila. I led product and strategy. Valence was acquired by Recursion (NASDAQ: RXRX) in May 2023. I stayed on afterwards to help build out the AI research engine of Recursion called Valence Labs. Biochemist by training | Waterloo graduate
Ex-company, school and discipline below are derived from this bio. Nothing is inferred when the bio is missing.
BACKGROUND
Credentialsnone mentioned
DisciplineResearcherKeyword match from the bio text, not a classifier.
TRACK RECORD
Exit mentioned in bio
COMPANY CONTEXT
RNA intelligence for precision medicine